No Data
No Data
Grifols Raised to Hold From Sell by Deutsche Bank
Grifols Raised to Hold From Sell by Deutsche Bank
RAAS Blood Products Renews Cooperation Deal With Spain's Grifols
Shanghai RAAS Blood Products (SHE:002252) renewed its cooperation agreement with Spanish healthcare company Grifols, according to a Tuesday filing on the Shenzhen Stock Exchange. Both parties will con
Deutsche Numis Upgrades Grifols(GRFS.US) to Hold Rating
Deutsche Numis analyst Emmanuel Papadakis upgrades $Grifols(GRFS.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 58.9% and a total average return of 5.9% over the p
Grifols completed the sale of 20% of Shanghai RAAS Blood Products shares and reached a global strategy cooperation agreement with Haier Group.
With today's completed trade announcement, Grifols and Haier will collaborate through Shanghai RAAS to enhance China's medical care system. Through a stock purchase agreement, Grifols is selling 20% of Shanghai RAAS's shares to Haier Group for RMB 12.5 billion (approximately 1.6 billion euros). Grifols and Shanghai RAAS have extended their exclusive agent agreement for albumin for the next 10 years, and Shanghai RAAS can choose to extend it until 2044. All of Grifols' earnings will be used to fulfill its deleveraging commitments. Shanghai, June 18, 2024 / PR Newswire / - Global medical and health enterprises.
Express News | Grifols Completes 20% Equity Stake Sale In SRAAS And Inks Partnership With Haier Group
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks were softer late Monday afternoon with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%. The iShares Biotechnology ETF (IBB) fell 0
TrytosaveabitOP : The Spanish pharmaceutical group said Monday it plans to launch the intravenous immunoglobulin therapeutic in the US within the year.